---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-028661"
form_type: "8-K"
ticker: "IXHL"
cik: "0001873875"
company_name: "Incannex Healthcare Inc."
filed_at: "2026-03-17T23:59:59+00:00"
generated_at: "2026-05-15T10:56:51.434525+00:00"
event_type: "other"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Incannex regains Nasdaq minimum bid price compliance; listing overhang removed

## Summary
- Nasdaq confirmed compliance after IXHL closed at ≥$1.00 for 11 consecutive business days through March 13, 2026.
- Company had previously disclosed bid price deficiency in April and October 2025; matter is now closed.
- CEO Joel Latham highlighted $75M cash, no debt, and pipeline progress (IHL-42X, PSX-001).
- Regaining compliance ensures continued listing on Nasdaq Capital Market, removing a technical overhang.

## SEC filing metadata
- accession: 0001213900-26-028661
- form_type: 8-K
- ticker: IXHL
- cik: 0001873875
- company_name: Incannex Healthcare Inc.
- filed_at: 2026-03-17T23:59:59+00:00
- event_type: other
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1873875/000121390026028661/0001213900-26-028661-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1873875/000121390026028661/ea0281000-8k_incannex.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-028661
- JSON: https://secwatch.observer/filing/0001213900-26-028661.json
- Plain text: https://secwatch.observer/filing/0001213900-26-028661.txt

## Source-grounded claims
- claim_id: 15a8173d639a8a7ec280a24e69a60bb61b2f2dcf
  claim: Incannex Healthcare Inc. received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).
  evidence_excerpt: March 16, 2026, Incannex Healthcare Inc. (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the bid price deficiency under Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Price Rule"), which the Company previously reported on in its Current Reports on Form 8-K filed on April 23, 2025 and Form 8-K filed on October 21, 2025, has been cured, and that the Company is now in compliance with the Minimum Bid Price Rule.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1873875/000121390026028661/0001213900-26-028661-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.